VANIQA Rx

Select the drug indication to add to your list

VANIQA

Miscellaneous dermatological conditions
Only 4 drugs may be compared at once

Generic Name and Formulations:

Eflornithine HCl 13.9%; crm.

Company:

Allergan

Select therapeutic use:

Indications for VANIQA:

Reduction of unwanted facial hair in women.

Adult:

Apply a thin layer to affected areas of face and adjacent areas under the chin twice daily at least 8 hours apart; rub in thoroughly. Do not wash treated area for at least 4 hours. Continue to use hair removal techniques as needed. May apply cosmetics or sunscreens after cream dries.

Children:

Not recommended.

Warnings/Precautions:

Reduce frequency if irritation or intolerance develops; discontinue if irritation continues. Abraded or broken skin. Pregnancy (Cat.C): not recommended. Nursing mothers.

Pharmacological Class:

Hair growth retardant.

Adverse Reactions:

Acne, pseudofolliculitis barbae, stinging, headache, burning, dry skin, erythema, tingling, dyspepsia, irritation, rash, alopecia, dizziness.

How Supplied:

Crm—30g, 60g (2x30g)

VANIQA 45g of 13.9% tube of creams (Qty:1)

appx. price $163.00